Julphar Focuses On Quality As Carle Departs

Anticipating Re-Inspections Of Flawed Facility

As its CEO Jerome Carle steps down following a 67% slump in sales to date this year, UAE-based Julphar is hopeful of putting manufacturing problems behind it under a new management team.

Julphar_Towers
Julphar is awaiting re-inspections of its key facility in Ras Al Khaimah, UAE, that it hopes will reopen export markets • Source: Shutterstock

Troubled United Arab Emirates drugmaker Julphar says it is focusing on “improving quality procedures” to overcome bans on exports to countries including Saudi Arabia, Bahrain, Kuwait and Oman. A new management team is trying to revive the flagging firm’s fortunes after CEO Jerome Carle departed on 8 December.

Julphar’s dramatic downturn in fortunes over the past year has stemmed from export bans following inspections of its key facility...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business